Translational Biology
Turn a computational hypothesis into an investable evidence package
USD 55–160K · 10–18 weeks · Validation report with go / no-go recommendation
At a glance
- Price band
- USD 55–160K
- Duration
- 10–18 weeks
- Deliverable
- Go / no-go report
- Data
- Raw + QC records
Indicative list price. Final scope and price confirmed in the proposal.
Talk to a scientistThe problem
Why teams buy this
Computational and literature evidence will not carry an investment committee, a partner or a board. And the internal laboratory that could produce the confirming data is at capacity - it always is.
What you get
Deliverables, not activity
- A validation study report with an explicit go / no-go recommendation
- Raw and processed data with complete QC records
- Expression, localisation and functional datasets
- Interpretation against the original computational hypothesis, including where it did not hold
How it works
The sequence
Validation strategy and model-system selectionExpression and localisation profilingKnockdown, knockout or inhibitionFunctional and phenotypic readoutsIntegrated interpretation
Who this is for
Biotech pre-Series A and pre-partnering · pharma discovery · academic translational groups · anyone who has to defend a target choice to someone holding a chequebook.
Proof
Representative result
Knockdown of a predicted target reduced fibrotic marker expression by 68% across three primary cell lines.
Representative programme - illustrates typical scope and outcomes; not an individual client account. Client-specific references are available on request under confidentiality.
Next
What we would suggest next
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.